Effectiveness of Low-Dose Itraconazole in Fungal-Associated Severe Asthma: A Retrospective Study

References

• Hekking PP, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135(4):896–902. doi:10.1016/j.jaci.2014.08.04225441637
   PubMed Web of Science ®Google Scholar
• Barry LE, Sweeney J, O’Neill C, Price D, Heaney LG. The cost of systemic corticosteroid-induced morbidity in severe asthma: a health economic analysis. Respir Res. 2017;18(1):129. doi:10.1186/s12931-017-0614-x28651591
   PubMed Web of Science ®Google Scholar
• Chen HC, Huang CD, Chang E, Kuo HP. Efficacy of omalizumab (Xolair (R)) in patients with moderate to severe predominately chronic oral steroid dependent asthma in Taiwan: a retrospective, population-based database cohort study. BMC Pulm Med. 2016;16(1):3. doi:10.1186/s12890-015-0156-226747278
   PubMed Web of Science ®Google Scholar
• Medrek SK, Kao CC, Yang DH, Hanania NA, Parulekar AD. Fungal sensitization is associated with increased risk of life-threatening asthma. J Allergy Clin Immunol Pract. 2017;5(4):1025–1031 e1022. doi:10.1016/j.jaip.2016.11.01528017627
   PubMed Web of Science ®Google Scholar
• Agarwal R, Nath A, Aggarwal AN, Gupta D, Chakrabarti A. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in North India. Mycoses. 2010;53(2):138–143. doi:10.1111/j.1439-0507.2008.01680.x19207831
   PubMed Web of Science ®Google Scholar
• O’Driscoll BR, Hopkinson LC, Denning DW. Mold sensitization is common amongst patients with severe asthma requiring multiple hospital admissions. BMC Pulm Med. 2005;5(1):4. doi:10.1186/1471-2466-5-415720706
   PubMedGoogle Scholar
• Denning DW, O’Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J. 2006;27(3):615–626.16507864
   PubMed Web of Science ®Google Scholar
• Fairs A, Agbetile J, Hargadon B, et al. IgE sensitization to aspergillus fumigatus is associated with reduced lung function in asthma. Am J Respir Crit Care Med. 2010;182(11):1362–1368. doi:10.1164/rccm.201001-0087OC20639442
   PubMed Web of Science ®Google Scholar
• Goh KJ, Yii ACA, Lapperre TS, et al. Sensitization to aspergillus species is associated with frequent exacerbations in severe asthma. J Asthma Allergy. 2017;10:131–140. doi:10.2147/JAA.S13045928461762
   PubMed Web of Science ®Google Scholar
• Agbetile J, Fairs A, Desai D, et al. Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1. Clin Exp Allergy. 2012;42(5):782–791. doi:10.1111/j.1365-2222.2012.03987.x22515394
   PubMed Web of Science ®Google Scholar
• Denning DW, O’Driscoll BR, Powell G, et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: the Fungal Asthma Sensitization Trial (FAST) study. Am J Respir Crit Care Med. 2009;179(1):11–18. doi:10.1164/rccm.200805-737OC18948425
   PubMed Web of Science ®Google Scholar
• Agbetile J, Bourne M, Fairs A, et al. Effectiveness of voriconazole in the treatment of aspergillus fumigatus-associated asthma (EVITA3 study). J Allergy Clin Immunol. 2014;134(1):33–39. doi:10.1016/j.jaci.2013.09.05024290286
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma., National Heart Lung and Blood Institute. Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention. 2014 revision ed. Bethsda, MD: U.S. Dept. of Health and Human Services, Public Health Service; 2014.
   Google Scholar
• Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180(1):59–99.19535666
   PubMed Web of Science ®Google Scholar
• Agarwal R, Chakrabarti A, Shah A, et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy. 2013;43(8):850–873.23889240
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.0003480516055882
   PubMed Web of Science ®Google Scholar
• Hernberg S, Sripaiboonkij P, Quansah R, Jaakkola JJK, Jaakkola MS. Lung function is reduced among subjects with asthma exposed to mold odor. Chest. 2014;146(1):e28–e29. doi:10.1378/chest.14-058225010976
   PubMed Web of Science ®Google Scholar
• Menzies D, Holmes L, McCumesky G, Prys-Picard C, Niven R. Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma. Allergy. 2011;66(5):679–685. doi:10.1111/j.1398-9995.2010.02542.x21261660
   PubMed Web of Science ®Google Scholar
• Porter PC, Lim DJ, Maskatia ZK, et al. Airway surface mycosis in chronic TH2-associated airway disease. J Allergy Clin Immunol. 2014;134(2):325–331. doi:10.1016/j.jaci.2014.04.02824928648
   PubMed Web of Science ®Google Scholar
• Masaki K, Fukunaga K, Matsusaka M, et al. Characteristics of severe asthma with fungal sensitization. Ann Allergy Asthma Immunol. 2017;119(3):253–257.28801088
   PubMed Web of Science ®Google Scholar
• Rick EM, Woolnough K, Pashley CH, Wardlaw AJ. Allergic fungal airway disease. J Investig Allergol Clin Immunol. 2016;26(6):344–354. doi:10.18176/jiaci.0122
   PubMed Web of Science ®Google Scholar
• Castanhinha S, Sherburn R, Walker S, et al. Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33. J Allergy Clin Immunol. 2015;136(2):312–322 e317. doi:10.1016/j.jaci.2015.01.01625746970
   PubMed Web of Science ®Google Scholar
• Lefebvre P, Duh MS, Lafeuille MH, et al. Acute and chronic systemic corticosteroid-related complications in patients with severe asthma. J Allergy Clin Immunol. 2015;136(6):1488–1495. doi:10.1016/j.jaci.2015.07.04626414880
   PubMed Web of Science ®Google Scholar
• Fraczek MG, Chishimba L, Niven RM, et al. Corticosteroid treatment is associated with increased filamentous fungal burden in allergic fungal disease. J Allergy Clin Immunol. 2018;142(2):407–414. doi:10.1016/j.jaci.2017.09.03929122659
   PubMed Web of Science ®Google Scholar